Citigroup’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.9M | Buy |
386,297
+52,407
| +16% | +$1.89M | 0.01% | 864 |
|
|
2025
Q1 | $10.4M | Sell |
333,890
-23,145
| -6% | -$721K | 0.01% | 963 |
|
|
2024
Q4 | $9.11M | Sell |
357,035
-171,467
| -32% | -$4.37M | 0.01% | 1014 |
|
|
2024
Q3 | $15M | Sell |
528,502
-66,237
| -11% | -$1.87M | 0.01% | 775 |
|
|
2024
Q2 | $15.7M | Buy |
594,739
+122,896
| +26% | +$3.24M | 0.01% | 721 |
|
|
2024
Q1 | $14.3M | Buy |
471,843
+143,850
| +44% | +$4.37M | 0.01% | 752 |
|
|
2023
Q4 | $9.21M | Buy |
327,993
+48,840
| +17% | +$1.37M | 0.01% | 883 |
|
|
2023
Q3 | $7.58M | Buy |
279,153
+32,580
| +13% | +$884K | 0.01% | 895 |
|
|
2023
Q2 | $7.58M | Buy |
246,573
+74,629
| +43% | +$2.29M | 0.01% | 918 |
|
|
2023
Q1 | $6.2M | Buy |
171,944
+69,140
| +67% | +$2.49M | ﹤0.01% | 1020 |
|
|
2022
Q4 | $4.06M | Sell |
102,804
-20,479
| -17% | -$809K | ﹤0.01% | 1139 |
|
|
2022
Q3 | $4.95M | Buy |
123,283
+8,893
| +8% | +$357K | ﹤0.01% | 1139 |
|
|
2022
Q2 | $4.81M | Sell |
114,390
-39,557
| -26% | -$1.66M | ﹤0.01% | 1142 |
|
|
2022
Q1 | $6M | Buy |
153,947
+37,054
| +32% | +$1.44M | ﹤0.01% | 1115 |
|
|
2021
Q4 | $4.66M | Sell |
116,893
-13,665
| -10% | -$545K | ﹤0.01% | 1335 |
|
|
2021
Q3 | $4.72M | Buy |
130,558
+12,913
| +11% | +$467K | ﹤0.01% | 1338 |
|
|
2021
Q2 | $4.82M | Sell |
117,645
-47,690
| -29% | -$1.96M | ﹤0.01% | 1442 |
|
|
2021
Q1 | $7.21M | Buy |
165,335
+104,955
| +174% | +$4.58M | ﹤0.01% | 1164 |
|
|
2020
Q4 | $3.02M | Buy |
60,380
+22,554
| +60% | +$1.13M | ﹤0.01% | 1481 |
|
|
2020
Q3 | $1.59M | Buy |
37,826
+37,626
| +18,813% | +$1.58M | ﹤0.01% | 1641 |
|
|
2020
Q2 | $10K | Buy |
+200
| New | +$10K | ﹤0.01% | 4643 |
|